nach oben

Erschienen in:

01.08.2012 | Schwerpunkt

Ausdauer- und Krafttraining bei Patienten mit Diabetes mellitus Typ 2 und Herzinsuffizienz

verfasst von: D. Niederseer, Prof. Dr. Dr. J. Niebauer, MBA

Erschienen in: Herz | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Typ-2-Diabetiker mit Herzinsuffizienz stellen eine immer größer werdende Patientengruppe dar. Nachweislich profitieren diese Patienten von körperlichem Training. Die in zahlreichen Studien gezeigten positiven Veränderungen in Bezug auf kardiovaskuläre Risikofaktoren, Morbidität und Mortalität lassen sich nur durch langfristige Trainingsprogramme in Form einer Kombination aus Ausdauer- und Krafttraining erzielen. Dieses wirksame und kostengünstige Therapeutikum sollte möglichst vielen Patienten angeboten werden.

Rubler S, Dlugash J, Yuceoglu YZ et al (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595–602PubMedCrossRef

Zarich SW, Nesto RW (1989) Diabetic cardiomyopathy. Am Heart J 118:1000–1012PubMedCrossRef

Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213–3223PubMedCrossRef

Fein FS (1990) Diabetic cardiomyopathy. Diabetes Care 13:1169–1179PubMedCrossRef

Bell DS (1995) Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 18:708–714PubMedCrossRef

Poirier P, Bogaty P, Garneau C et al (2001) Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24:5–10PubMedCrossRef

Schannwell CM, Schneppenheim M, Perings S et al (2002) Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98:33–39PubMedCrossRef

Resl M, Hulsmann M, Pacher R, Clodi M (2009) Heart failure in diabetes. Wien Med Wochenschr 159:134–140PubMedCrossRef

Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29–34PubMedCrossRef

10.

Nichols GA, Hillier TA, Erbey JR, Brown JB (2001) Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 24:1614–1619PubMedCrossRef

11.

Bertoni AG, Hundley WG, Massing MW et al (2004) Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 27:699–703PubMedCrossRef

12.

Iribarren C, Karter AJ, Go AS et al (2001) Glycemic control and heart failure among adult patients with diabetes. Circulation 103:2668–2673PubMedCrossRef

13.

Bertoni AG, Tsai A, Kasper EK, Brancati FL (2003) Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 26:2791–2795PubMedCrossRef

14.

Nichols GA, Gullion CM, Koro CE et al (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27:1879–1884PubMedCrossRef

15.

Barzilay JI, Kronmal RA, Gottdiener JS et al (2004) The association of fasting glucose levels with congestive heart failure in diabetic adults > or = 65 years: the Cardiovascular Health Study. J Am Coll Cardiol 43:2236–2241PubMedCrossRef

16.

Carr AA, Kowey PR, Devereux RB et al (2005) Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies. Am J Cardiol 96:1530–1536PubMedCrossRef

17.

Halon DA, Merdler A, Flugelman MY et al (2000) Late-onset heart failure as a mechanism for adverse long-term outcome in diabetic patients undergoing revascularization (a 13-year report from the Lady Davis Carmel Medical Center registry). Am J Cardiol 85:1420–1426PubMedCrossRef

18.

Greenberg BH, Abraham WT, Albert NM et al (2007) Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 154:277.e1–e8PubMed

19.

Murray AJ, Anderson RE, Watson GC et al (2004) Uncoupling proteins in human heart. Lancet 364:1786–1788PubMedCrossRef

20.

Swan JW, Anker SD, Walton C et al (1997) Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 30:527–532PubMedCrossRef

21.

Pogatsa G (2001) Metabolic energy metabolism in diabetes: therapeutic implications. Coron Artery Dis 12(Suppl 1):29–33

22.

Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442PubMedCrossRef

23.

Von Bibra H, Thrainsdottir IS, Hansen A et al (2005) Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 2:24–30CrossRef

24.

Epshteyn V, Morrison K, Krishnaswamy P et al (2003) Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care 26:2081–2087PubMedCrossRef

25.

Zannad F, Briancon S, Juilliere Y et al (1999) Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l’Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol 33:734–742PubMedCrossRef

26.

Kristiansson K, Sigfusson N, Sigvaldason H, Thorgeirsson G (1995) Glucose tolerance and blood pressure in a population-based cohort study of males and females: the Reykjavik Study. J Hypertens 13:581–586PubMedCrossRef

27.

McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446PubMedCrossRef

28.

He J, Ogden LG, Bazzano LA et al (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161:996–1002PubMedCrossRef

29.

Hu FB, Stampfer MJ, Haffner SM et al (2002) Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25:1129–1134PubMedCrossRef

30.

Ryden L, Standl E, Bartnik M et al (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28:88–136PubMedCrossRef

31.

Solang L, Malmberg K, Ryden L (1999) Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J 20:789–795PubMedCrossRef

32.

(n a) (2012) Standards of medical care in diabetes – 2012. Diabetes Care 35(Suppl 1):S11–S63

33.

Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10:933–989PubMedCrossRef

34.

Niederseer D, Thaler C, Niebauer J (2007) The failing heart. N Engl J Med 356:2545PubMed

35.

Berger M, Berchtold P, Cuppers HJ et al (1977) Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia 13:355–365PubMedCrossRef

36.

Poirier P, Tremblay A, Catellier C et al (2000) Impact of time interval from the last meal on glucose response to exercise in subjects with type 2 diabetes. J Clin Endocrinol Metab 85:2860–2864PubMedCrossRef

37.

Fang ZY, Sharman J, Prins JB, Marwick TH (2005) Determinants of exercise capacity in patients with type 2 diabetes. Diabetes Care 28:1643–1648PubMedCrossRef

38.

Devlin JT (1992) Effects of exercise on insulin sensitivity in humans. Diabetes Care 15:1690–1693PubMedCrossRef

39.

Schneider SH, Amorosa LF, Khachadurian AK, Ruderman NB (1984) Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes. Diabetologia 26:355–360PubMedCrossRef

40.

Henriksson J (1992) Effects of physical training on the metabolism of skeletal muscle. Diabetes Care 15:1701–1711PubMedCrossRef

41.

Mayer-Davis EJ, D’Agostino R Jr, Karter AJ et al (1998) Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA 279:669–674PubMedCrossRef

42.

Boule NG, Haddad E, Kenny GP et al (2001) Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286:1218–1227PubMedCrossRef

43.

Snowling NJ, Hopkins WG (2006) Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care 29:2518–2527PubMedCrossRef

44.

Umpierre D, Ribeiro PA, Kramer CK et al (2011) Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA 305:1790–1799PubMedCrossRef

45.

Chudyk A, Petrella RJ (2011) Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis. Diabetes Care 34:1228–1237PubMedCrossRef

46.

Sigal RJ, Kenny GP, Boule NG et al (2007) Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 147:357–369PubMed

47.

Church TS, Blair SN, Cocreham S et al (2010) Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. JAMA 304:2253–2262PubMedCrossRef

48.

Gregg EW, Gerzoff RB, Caspersen CJ et al (2003) Relationship of walking to mortality among US adults with diabetes. Arch Intern Med 163:1440–1447PubMedCrossRef

49.

Tanasescu M, Leitzmann MF, Rimm EB, Hu FB (2003) Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation 107:2435–2439PubMedCrossRef

50.

Hu FB, Stampfer MJ, Solomon C et al (2001) Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med 134:96–105PubMed

51.

Wei M, Gibbons LW, Kampert JB et al (2000) Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 132:605–611PubMed

52.

O’Connor CM, Whellan DJ, Lee KL et al (2009) Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301:1439–1450CrossRef

53.

Davies EJ, Moxham T, Rees K et al (2010) Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev (4):CD003331

54.

Flynn KE, Pina IL, Whellan DJ et al (2009) Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301:1451–1459PubMedCrossRef

55.

Haykowsky MJ, Liang Y, Pechter D et al (2007) A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Cardiol 49:2329–2336PubMedCrossRef

56.

Hambrecht R, Gielen S, Linke A et al (2000) Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial. JAMA 283:3095–3101PubMedCrossRef

57.

(n a) (1998) Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance. European Heart Failure Training Group. Eur Heart J 19:466–475

58.

Pina IL, Apstein CS, Balady GJ et al (2003) Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 107:1210–1225PubMedCrossRef

59.

Rees K, Taylor RS, Singh S et al (2004) Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev (3):CD003331

60.

Smart N, Marwick TH (2004) Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med 116:693–706PubMedCrossRef

61.

Wisloff U, Stoylen A, Loennechen JP et al (2007) Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115:3086–3094PubMedCrossRef

62.

Kitzman DW, Hundley WG, Brubaker PH et al (2010) A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility. Circ Heart Fail 3:477–485PubMedCrossRef

63.

McKelvie RS, Teo KK, McCartney N et al (1995) Effects of exercise training in patients with congestive heart failure: a critical review. J Am Coll Cardiol 25:789–796PubMedCrossRef

64.

Belardinelli R, Georgiou D, Cianci G, Purcaro A (1996) Effects of exercise training on left ventricular filling at rest and during exercise in patients with ischemic cardiomyopathy and severe left ventricular systolic dysfunction. Am Heart J 132:61–70PubMedCrossRef

65.

Sixt S, Beer S, Bluher M et al (2010) Long- but not short-term multifactorial intervention with focus on exercise training improves coronary endothelial dysfunction in diabetes mellitus type 2 and coronary artery disease. Eur Heart J 31:112–119PubMedCrossRef

66.

Edelmann F, Gelbrich G, Dungen HD et al (2011) Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol 58:1780–1791PubMedCrossRef

67.

Liu JL, Irvine S, Reid IA et al (2000) Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure: a role for angiotensin II. Circulation 102:1854–1862PubMedCrossRef

68.

Roveda F, Middlekauff HR, Rondon MU et al (2003) The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. J Am Coll Cardiol 42:854–860PubMedCrossRef

69.

Braith RW, Welsch MA, Feigenbaum MS et al (1999) Neuroendocrine activation in heart failure is modified by endurance exercise training. J Am Coll Cardiol 34:1170–1175PubMedCrossRef

70.

Hambrecht R, Fiehn E, Weigl C et al (1998) Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98:2709–2715PubMedCrossRef

71.

Varin R, Mulder P, Richard V et al (1999) Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress. Circulation 99:2951–2957PubMedCrossRef

72.

Sixt S, Rastan A, Desch S et al (2008) Exercise training but not rosiglitazone improves endothelial function in prediabetic patients with coronary disease. Eur J Cardiovasc Prev Rehabil 15:473–478PubMedCrossRef

73.

Desch S, Sonnabend M, Niebauer J et al (2010) Effects of physical exercise versus rosiglitazone on endothelial function in coronary artery disease patients with prediabetes. Diabetes Obes Metab 12:825–828PubMedCrossRef

74.

Hambrecht R, Hilbrich L, Erbs S et al (2000) Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol 35:706–713PubMedCrossRef

75.

Niebauer J, Clark AL, Webb-Peploe KM, Coats AJ (2005) Exercise training in chronic heart failure: effects on pro-inflammatory markers. Eur J Heart Fail 7:189–193PubMedCrossRef

76.

Niebauer J, Clark AL, Webb-Peploe KM et al (2005) Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure. Eur J Heart Fail 7:183–188PubMedCrossRef

77.

Goodpaster BH, Park SW, Harris TB et al (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61:1059–1064PubMedCrossRef

78.

Nelson ME, Rejeski WJ, Blair SN et al (2007) Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 116:1094–1105PubMedCrossRef

79.

Niederseer D, Niebauer J (2010) Möglichkeiten und Risiken des Krafttrainings. Ärzte Woche 24:14

80.

Weitgasser R, Brath H, Niebauer J (2009) Lebensstil: Diagnostik und Therapie. Wien Klin Wochenschr 121:10–12

81.

Cauza E, Hanusch-Enserer U, Strasser B et al (2005) The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Arch Phys Med Rehabil 86:1527–1533PubMedCrossRef

82.

Dunstan DW, Daly RM, Owen N et al (2002) High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care 25:1729–1736PubMedCrossRef

83.

Castaneda C, Layne JE, Munoz-Orians L et al (2002) A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care 25:2335–2341PubMedCrossRef

84.

Sigal RJ, Kenny GP, Wasserman DH et al (2006) Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29:1433–1438PubMedCrossRef

85.

Maron BJ, Araújo CGS, Thompson PD et al (2001) Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes: an advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 103:327–334PubMedCrossRef

86.

Niebauer J (2008) Effects of exercise training on inflammatory markers in patients with heart failure. Heart Fail Rev 13:39–49PubMedCrossRef

87.

Lemaster JW, Reiber GE, Smith DG et al (2003) Daily weight-bearing activity does not increase the risk of diabetic foot ulcers. Med Sci Sports Exerc 35:1093–1099PubMedCrossRef

88.

Bjarnason-Wehrens B, Mayer-Berger W, Meister ER et al (2004) Recommendations for resistance exercise in cardiac rehabilitation. Recommendations of the German Federation for Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 11:352–361PubMedCrossRef

89.

Bjarnason-Wehrens B, Mayer-Berger W, Meister ER et al (2004) The stakes of force perseverance training and muscle structure training in rehabilitation. Recommendations of the German Federation for Prevention and Rehabilitation of Heart-Circulatory Diseases e.v. Z Kardiol 93:357–370PubMedCrossRef

90.

Niebauer J, Hambrecht R, Marburger C et al (1995) Impact of intensive physical exercise and low-fat diet on collateral vessel formation in stable angina pectoris and angiographically confirmed coronary artery disease. Am J Cardiol 76:771–775PubMedCrossRef

91.

Lewis JD, Ferrara A, Peng T et al (2011) Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care 34:916–922PubMedCrossRef

92.

Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501–2555PubMedCrossRef

Titel: Ausdauer- und Krafttraining bei Patienten mit Diabetes mellitus Typ 2 und Herzinsuffizienz
verfasst von: D. Niederseer
Prof. Dr. Dr. J. Niebauer, MBA
Publikationsdatum: 01.08.2012
Verlag: Urban and Vogel
Erschienen in: Herz / Ausgabe 5/2012
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-012-3635-8

Neu im Fachgebiet Kardiologie

16.04.2024 | Chronische Herzinsuffizienz | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Ausdauer- und Krafttraining bei Patienten mit Diabetes mellitus Typ 2 und Herzinsuffizienz

Zusammenfassung

Neu im Fachgebiet Kardiologie

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Selbstexpandierende TAVI-Klappen bei kleinem Aortenanulus im Vorteil

Verbesserung der HDL-Funktion als Lipidtherapie floppt in Mega-Studie

Update Kardiologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2012

The effect of training on performance and health in middle age

Leiomyosarcoma of the inferior vena cava extending into the right atrium

Molekulare Mechanismen der Herz- und Gefäßanpassung durch Sport

Carotid intima-media thickness and serum leptin in psoriasis

EKG-Diagnostik bei Leistungssportlern

Vasospastic angina in a patient with hyperthyroidism

Neu im Fachgebiet Kardiologie

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Selbstexpandierende TAVI-Klappen bei kleinem Aortenanulus im Vorteil

Verbesserung der HDL-Funktion als Lipidtherapie floppt in Mega-Studie

Update Kardiologie